Europe — EMA
Oxlumo (Lumasiran)
Lumasiran, the active ingredient in Oxlumo, is an RNA‑RNA therapeutic presented as a solution for subcutaneous injection use. It treats primary hyperoxaluria type 1 in patients of all ages.
Request sourcing
1
Pack/s
What is Lumasiran?
Lumasiran, the active ingredient in Oxlumo, is an RNA‑RNA therapeutic presented as a solution for subcutaneous injection use. It treats primary hyperoxaluria type 1 in patients of all ages.
GNH USA supplies Oxlumo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.
What is Lumasiran used for?
Oxlumo targets ... - Primary .... .... .... .... .... .... ... .... .... ... ... .... ... ... ... ... ... ... ",
.... ...
Product details
Drug
Lumasiran
Route
Subcutaneous Use
Manufacturer
Alnylam Netherlands B.V.
Origin
EU
